Picture of Galectin Therapeutics logo

GALT — Galectin Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

U.S. STOCKS ON THE MOVE-Discovery, Nikola, Moderna, Galectin

* Eikon search string for individual stock moves:  STXBZ 
    * The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
    * The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh

U.S. stock index futures rose on Wednesday ahead of quarterly earnings reports
from JPMorgan and Goldman Sachs, with investors expecting a strong rebound for
corporate America against the backdrop of a swift vaccine-led global economic
recovery.  .N 
    At 6:49 ET, Dow e-minis  1YMc1  were down 0.02% at 33,564. S&P 500 e-minis
 ESc1  were up 0.08% at 4,136, while Nasdaq 100 e-minis  NQc1  were up 0.16% at
13,998.5.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Oceaneering International Inc  OII , up 9.6%
 ** FLEX LNG Ltd  FLNG.K , up 8.8%
 ** ION Geophysical Corporation  IO , up 7.9%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Talos Energy Inc  TALO.K , down 4.2%
 ** Finance of America Companies Inc  FOA , down 4.1%
 ** X FINANCIAL  XYF , down 3.7%
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Galectin Therapeutics Inc  GALT.O , up 30.3%
 ** Bit Digital Inc  BTBT.O , up 20.5%
 ** UTStarcom Holdings Corp  UTSI.O , up 16.1%
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Cellectar Biosciences Inc  CLRBZ.O , down 23.7%
 ** USA Technologies Inc  USAT.O , down 15%
 ** Andina Acquisition Corp III  ANDAR.O , down 14%
 
 
 ** Stitch Fix  SFIX.O : down 2.9% premarket
 BUZZ-Falls as founder steps down as CEO  urn:newsml:reuters.com:*:nL4N2M647R
    
 ** Discovery Inc  DISCA.O : down 4.0% premarket
 ** iQIYI  IQ.O : down 3.7% premarket   
 BUZZ-Slump as Credit Suisse markets large blocks  urn:newsml:reuters.com:*:nL1N2M62O8    
    
 ** Moderna  MRNA.O : up 1.5% premarket
 BUZZ-Rises after COVID-19 vaccine shows long-lasting efficacy  urn:newsml:reuters.com:*:nL4N2M72Q8
    
 ** Galectin  GALT.O : up 30.3% premarket
 BUZZ-Soars on data showing lead drug's potential in cancer treatment
 urn:newsml:reuters.com:*:nL4N2M72QB
    
 ** Nikola  NKLA.O : up 4.5% premarket
 BUZZ-Up on collaboration with Iveco, OGE for hydrogen infrastructure
 urn:newsml:reuters.com:*:nL4N2M72PZ
    

 (Compiled by Sahil Shaw in Bengaluru)
 ((sahil.shaw@thomsonreuters.com))

Recent news on Galectin Therapeutics

See all news